Compare XPEV & GMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XPEV | GMED |
|---|---|---|
| Founded | 2015 | 2003 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5B | 11.0B |
| IPO Year | 2020 | 2012 |
| Metric | XPEV | GMED |
|---|---|---|
| Price | $10.97 | $78.45 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 14 |
| Target Price | $23.08 | ★ $100.42 |
| AVG Volume (30 Days) | ★ 6.6M | 1.3M |
| Earning Date | 05-20-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 422.67 |
| EPS | N/A | ★ 2.00 |
| Revenue | N/A | ★ $2,938,931,000.00 |
| Revenue This Year | $25.76 | $11.13 |
| Revenue Next Year | $25.98 | $6.28 |
| P/E Ratio | ★ N/A | $39.49 |
| Revenue Growth | N/A | ★ 16.65 |
| 52 Week Low | $10.72 | $54.17 |
| 52 Week High | $28.20 | $101.40 |
| Indicator | XPEV | GMED |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 39.26 |
| Support Level | N/A | $74.52 |
| Resistance Level | N/A | $82.23 |
| Average True Range (ATR) | 0.00 | 2.25 |
| MACD | 0.00 | -0.84 |
| Stochastic Oscillator | 0.00 | 7.03 |
Founded in 2015, XPeng is a leading Chinese smart electric vehicle company that designs, develops, manufactures, and markets EVs in China. Its products primarily target the growing base of technology-savvy middle-class consumers in the midrange to high-end segment in China's passenger vehicle market. The company sold about 430,000 EVs in 2025, accounting for about 3% of China's passenger new energy vehicle market. It is also a leader in autonomous driving technology.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.